HbA1c measurement – type 2 diabetes (PI05 and PI06)

Indicators related to HbA1c in the national Key Performance Indicators (nKPI) collection are:

  • HbA1c result recorded – type 2 diabetes (PI05): the proportion of First Nations regular clients with type 2 diabetes who had an HbA1c measurement result recorded within the previous 6 months or within the previous 12 months
  • HbA1c result – type 2 diabetes (PI06): the proportion of First Nations regular clients with type 2 diabetes who had an HbA1c measurement result recorded within the previous 6 months or within the previous 12 months as either (mmol/mol):
    • ≤53 (≤7%)
    • >53–≤64 (>7%–≤8%)
    • >64–<86 (>8%–<10%)
    • ≥86 (≥10%).

PI05 and PI06 are collected for males and females in age groups from 0–4 to 65 and over, and presented here for males and females in age groups:

  • under 35
  • 35–44
  • 45–54
  • 55–64
  • 65 and over.

Why HbA1c is important

The HbA1c (glycosylated haemoglobin or glycated haemoglobin) blood test gives an indication of whether blood glucose levels have been higher than normal over the preceding 6–8 weeks by looking at how much sugar (glucose) is bound in red blood cells. It is regarded as the gold standard for assessing glycaemic control.

People who have diabetes need this test regularly to see if their levels are staying within range and whether they need to adjust their diabetes management. The general glycated haemoglobin (HbA1c) target in people with type 2 diabetes is ≤53 mmol/mol (≤7%) (RACGP 2020).

HbA1c result recorded – type 2 diabetes (PI05)

At June 2022, of First Nations regular clients with type 2 diabetes:

  • 45% (or around 22,200) had an HbA1c measurement result recorded within the previous 6 months
  • 62% (or around 30,500) had an HbA1c measurement result recorded within the previous 12 months.

HbA1c result recorded – type 2 diabetes, by reporting period and time period

HbA1c result recorded—type 2 diabetes, by time period and reporting period

This Tableau visualisation shows the percentage of Indigenous regular clients with type 2 diabetes who had a HbA1c measurement result recorded by time period of measurement (select for 6 months or 12 months), for reporting periods from June 2017 to June 2022.

Data supporting this visualisation are available in Excel supplementary data tables at Data.

Note: See Technical notes for more information, including on interpreting changes over time..

 

Having an HbA1c measurement result recorded within the previous 6 months was highest in:

  • Victoria/Tasmania (combined) (52%)
  • Major cities (49%)
  • Aboriginal Community Controlled Health Organisations (ACCHOs) (47%).

HbA1c result recorded – type 2 diabetes, by reporting period, time period and state/territory or remoteness or organisation type

HbA1c result recorded—type 2 diabetes, by time period and either state/territory, remoteness or organisation type, reporting period

Two Tableau visualisations are presented here. The first shows the percentage of Indigenous regular clients with type 2 diabetes who had a HbA1c measurement result recorded by time period of measurement (select for 6 months or 12 months) for either:

  • state/territory (NSW/ACT, Vic, Qld, WA, SA, Tas, NT, Australia)
  • remoteness area (Major cities, Inner regional, Outer regional, Remote, Very remote, Australia)
  • organisation type (ACCHO, non-ACCHO, Total).

Reporting periods of either June 2017, December 2017, June 2018, December 2018, June 2019, December 2019, June 2020, December 2020, June 2021, December 2021, or June 2022 can be selected.

The second visualisation shows the selected information from the first visualisation by sex (male, female) and age group (<35, 35–44, 45–54, 55–64, 65+).

Data supporting this visualisation are available in Excel supplementary data tables at Archived content.

Note: See Technical notes for more information, including on interpreting changes over time..

HbA1c result – type 2 diabetes (PI06)

At June 2022:

  • 41% (or around 9,100) of First Nations regular clients with type 2 diabetes had an HbA1c measurement result of ≤53 mmol/mol recorded within the previous 6 months
  • 40% (or around 12,300) had an HbA1c measurement result of ≤53 mmol/mol recorded within the previous 12 months.

HbA1c result – type 2 diabetes, by reporting period, time period and result level

HbA1c result—type 2 diabetes, by time period and reporting period

This Tableau visualisation shows the percentage of Indigenous regular clients with type 2 diabetes who had a HbA1c measurement result recorded by time period of measurement (select for 6 months or 12 months), HbA1C result in mmol/mol (select for ≤53, >53–≤64, >64–<86, or ≥86), for reporting periods from June 2017 to June 2022.

Data supporting this visualisation are available in Excel supplementary data tables at Data.

Note: See Technical notes for more information, including on interpreting changes over time..

 

Having an HbA1c measurement result of ≤53 mmol/mol recorded within the previous 6 months was highest in:

  • New South Wales/the Australian Capital Territory (combined) (48%)
  • Inner regional areas (48%)
  • Aboriginal Community Controlled Health Organisations (ACCHOs) (42%).

HbA1c result – type 2 diabetes, by reporting period, time period, state/territory or remoteness or organisation type

HbA1c result—type 2 diabetes, by time period and either state/territory, remoteness or organisation type, reporting period

Two Tableau visualisations are presented here. The first shows the percentage of Indigenous regular clients with type 2 diabetes who had a HbA1c measurement result recorded by time period of measurement (select for 6 months or 12 months), HbA1C result in mmol/mol (select for ≤53, >53–≤64, >64–<86, or ≥86) for either:

  • state/territory (NSW/ACT, Vic, Qld, WA, SA, Tas, NT, Australia)
  • remoteness area (Major cities, Inner regional, Outer regional, Remote, Very remote, Australia)
  • organisation type (ACCHO, non-ACCHO, Total).

Reporting periods of either June 2017, December 2017, June 2018, December 2018, June 2019, December 2019, June 2020, December 2020, June 2021, December 2021, or June 2022 can be selected.

The second visualisation shows the selected information from the first visualisation by sex (male, female) and age group (<35, 35–44, 45–54, 55–64, 65+).

Data supporting this visualisation are available in Excel supplementary data tables at Archived content.

Note: See Technical notes for more information, including on interpreting changes over time.

Reference

RACGP (The Royal Australian College of General Practitioners) (2020) Management of type 2 diabetes: a handbook for general practice, RACGP, accessed 3 January 2023.

Previous page
Next page